An international team of researchers created a two-dimensional map that shows the geographical origins of 3,000 Europeans based on their genetic mutations.
GlaxoSmithKline participated in the effort because it could prove beneficial to genetic epidemiology, which involves populationwide studies. Such research could help drugmakers cut costs in testing adverse reactions to medicines. (Source:
MIT Technology Review)
No comments:
Post a Comment
Thanks for visiting.
Please be considerate... no off-topic, racist, sexist or homophobic comments.
Comment moderation is on.
No anonymous comments will be accepted..